capsule-cure-drugs-208512.jpg

South Korea takes steps to lower pharma prices

New measures put pressure on drug makers, importers and distributors

South Korea’s latest moves to make drugs more affordable are slowing down the growth of the pharma market in the country and maybe hurting sales of new and innovative drugs.

BMI Research predicts South Korean pharmaceutical will grow at 2.4% for the next 10 years, 1% less than expected. Elise Mak wrote about the changes in BioWorld (paywall) on May 4.

read more
louis-reed-747388-unsplash.jpg

R&D spend driving China pharma co’s

Companies are narrowing the gap

China is not a powerhouse of innovation, yet, but it is certainly trying to pay its way into that particular status. This willingness to spend in R&D – to pay to talent, buy innovative companies and seek out new technologies – is particularly visible in the pharmaceutical and biotechnology space. And it is working.

read more